REGEN-COV antibody cocktail shown to significantly lower SARS-CoV-2 viral load
The phase 1/2 trial of the REGEN-COV (casirivimab and imdevimab) antibody cocktail from Regeneron conducted on 799 individuals shows that
Read more
New antibody therapy may reverse diabetic retinopathy and other eye conditions
The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy—a protein
Read more
Researchers repurpose pre-existing anti-SARS-CoV antibody to develop potent neutralizing antibody against SARS-CoV-2
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing
Read more
Monoclonal antibody bamlanivimab reduces hospitalization and death in moderate-to-severe COVID-19
Monoclonal antibody treatment may help prevent coronavirus disease (COVID-19) complications. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
Read more
Sphere Fluidics announces enhanced Cyto-Mine capability and performance
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced it has enhanced
Read more
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses
Read more
Study provides new insight on how HER2-low tumors may evolve in breast cancer patients
The finding that breast tumors can evolve to express low HER2 potentially widens the number of patients who can benefit
Read more
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody
Read more
Recovered COVID-19 patients may need only a single vaccine dose, suggests study
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune
Read more
Eli Lilly to focus on selling COVID-19 antibody drug combination
FILE PHOTO: A sign is pictured outside an Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in
Read more